Published: 2018-12-08

Articles

PHARMACEUTICAL EXPENDITURE COMPARED ACROSS COUNTRIES

C. van Mosseveld
Abstract 272 | PDF Downloads 158

TOXIC EPIDERMAL NECROLYSIS AND CLARITHROMYCIN

Nadia Khaldi, Alain Miras, Sophie Gromb
Abstract 266 | PDF Downloads 261

COMPLIANCE ASSESSMENT IN DRUG TRIALS: HAS THERE BEEN IMPROVEMENT IN TWO DECADES?

Shiva Jayaraman, Michael J Rieder, Doreen M Matsui
Abstract 278 | PDF Downloads 530

CARDIOVASCULAR COLLAPSE FROM LOW DOSE BUPIVACAINE

Marc E Levsky, Michael A Miller
Abstract 1307 | PDF Downloads 604

ARE BRAND-NAME AND GENERIC WARFARIN INTERCHANGEABLE? A SURVEY OF ONTARIO PATIENTS AND PHYSICIANS

Jennifer A Pereira, Anne M Holbrook, Lisa Dolovich Dolovich, Charles Goldsmith, , Lehana Thabane, James D Douketis, Mark Crowther, Shannon M Bates, Jeffrey S Ginsberg
Abstract 417 | PDF Downloads 204

THE ROLE OF BUSPIRONE FOR THE TREATMENT OF CEREBELLAR ATAXIA IN AN OLDER INDIVIDUAL

Jayna M Holroyd-Leduc, Barbara A Liu, Brian E Mak I, Aleksandra Zecevic, Nathan Herrmann, Sandra E Black
Abstract 563 | PDF Downloads 157

CLINICAL TRIAL APPLICATIONS IN CANADA

Agnes V Klein, Anne M Tomalin
Abstract 370 | PDF Downloads 541